CAL-MAINE FOODS INC (CALM)       55.64  -1.53 (-2.68%)

55.64  -1.53 (-2.68%)

US1280302027 - Common Stock


Fundamental Rating

8

We assign a fundamental rating of 8 out of 10 to CALM. CALM was compared to 104 industry peers in the Food Products industry. CALM scores excellent points on both the profitability and health parts. This is a solid base for a good stock. CALM is valued quite cheap, while showing a decent growth score. This is a good combination! This makes CALM very considerable for value investing!.




Profitability

Profitability Rating

10

CALM's Return On Assets of 26.84% is amongst the best returns of the industry. CALM outperforms 100% of its industry peers. The industry average Return On Assets is 6.01%.
CALM's Return On Equity of 35.84% is amongst the best returns of the industry. CALM outperforms 93% of its industry peers. The industry average return on equity is 14.51%.

CALM has a Profit Margin of 18.71%. This is amongst the best returns in the industry. The industry average is 5.66%. CALM outperforms 95% of its industry peers.
CALM has a very good Piotroski-F score of 8.00. This indicates a great health and profitability for CALM.
VS Industry

ROA (26.84%) VS Industry: 100% outperformed.

0.13
26.84

ROE (35.84%) VS Industry: 93% outperformed.

0.23
82.65

Profit Margin (18.71%) VS Industry: 95% outperformed.

0.08
41.73

Valuation

Valuation Rating

8

The Price/Earnings Ratio is 5.74, which indicates a rather cheap valuation of CALM.
CALM's Price/Earning Ratio is rather cheap when compared to the industry average which is at 21.94. CALM is also cheaper than 98% of the companies in the same industry.
CALM's low PEG Ratio, which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
When comparing the Enterprise Value to EBITDA ratio of CALM to the average industry ratio of 14.47, CALM is valued rather cheaply. CALM is also cheaper than 90% of the companies listed in the same industry.

With a Forward Price/Earnings Ratio of 16.72, CALM is valued correctly.
With a price book ratio of 2.06, CALM is valued correctly.
When comparing the price book ratio of CALM to the average industry price book ratio of 1.94, CALM is valued in line with its industry peers.
VS Industry

Price/Earnings (5.74) VS Industry: 98% outperformed.

546.50
5.57

Price/Book (2.06) VS Industry: 43% outperformed.

250.05
0.03

Enterprise Value/ EBITDA (3.27) VS Industry: 90% outperformed.

665.34
0.89

Growth

Growth Rating

5

CALM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 6162.50%, which is quite impressive.
Measured over the past 5 years, CALM shows a very strong growth in Earnings Per Share. The EPS has been growing by 32.69% on average per year.
Looking at the last year, CALM shows a very strong growth in Revenue. The Revenue has grown by 78.76%.
Measured over the past 5 years, CALM shows a quite strong growth in Revenue. The Revenue has been growing by 10.59% on average per year.

The Earnings Per Share is expected to decrease by -4.97% on average over the next 5 years.
CALM is expected to show a small growth in Revenue. In the coming 5 years, the Revenue will grow by 3.56% yearly.
When comparing the EPS growth rate of the last years to the growth rate of the upcoming 5 years, we see that the growth is decreasing.
The Revenue growth is decreasing: in the next 5 years the growth will be less than in the last years.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPSN/A 32.69% 6162.5% 193.11% 10.83% -4.97% N/A
Revenue10.59% 9.3% 78.76% 35.95% 5.96% 3.56% N/A

Health

Health Rating

10

CALM has a Current Ratio of 3.18. This indicates that CALM is financially healthy and has no problem in meeting its short term obligations.
The Current Ratio of CALM is much better than the industry average of 1.80. CALM has a better rating than 85% of its industry peers.
A Quick Ratio of 2.26 indicates that CALM has no problem at all paying its short term obligations.
CALM is one of the better placed companies in its industry to meet its short term obligations. Its Current Ratio is much better than the industry average of 0.90. CALM has a better rating than 86% of its industry peers.

The Debt to Equity ratio of CALM is way better than the industry averages. CALM has a better rating than 91% of its industry peers.
CALM has an Altman-Z score of 7.84. This indicates that CALM is financially healthy and little risk of bankruptcy at the moment.
The Altman-Z score of CALM is much better than the industry average of 2.21. CALM has a better rating than 91% of its industry peers.
CALM has a very good Piotroski-F score of 8.00. This indicates a great health and profitability for CALM.
VS Industry

Debt/Equity (0) VS Industry: 91% outperformed.

53.34
0.00

Quick Ratio (2.26) VS Industry: 86% outperformed.

0.01
48.00

Current Ratio (3.18) VS Industry: 85% outperformed.

0.01
49.63

Altman-Z (7.84) VS Industry: 91% outperformed.

-34.87
75.23

Dividend

Dividend Rating

6

CALM has a Yearly Dividend Yield of 5.63%, which is a nice return.
CALM's Dividend Yield is a higher than the industry average which is at 2.97.

CALM's Dividend Yield is rather good when compared to the S&P500 average which is at 2.41.
CALM has paid a dividend for at least 10 years, which is a reliable track record.
VS Industry

Dividend Yield (5.63%) VS Industry: 77% outperformed.

0.73
17.92

CAL-MAINE FOODS INC55.64

NASDAQ:CALM (2/2/2023, 8:38:45 AM)-1.53 (-2.68%)

Chartmill FA Rating
GICS Sector Consumer Staples
GICS IndustryGroup Food, Beverage & Tobacco
GICS Industry Food Products
Earnings (Last) 12-28 2022-12-28 Earnings (Next) 03-27 2023-03-27
Inst Owners 83.37% Inst Owner Change -0.01%
Ins Owners 0.62% Ins Owner Change 2.05%
Market Cap 2.72B Analysts 51.11
Price Target 61.88 (11.21%)

Dividend
Dividend Yield 5.63% Dividend Growth N/A
DP N/A Ex-Date 01-24 2023-01-24 (1.351)

Surprises & Revisions
EPS beat(2) N/A Avg EPS beat(2) -3.73%
Min EPS beat(2) -5.89% Max EPS beat(2) -1.58%
EPS beat(4) 1 Avg EPS beat(4) 1.98%
Min EPS beat(4) -5.89% Max EPS beat(4) 19.72%
Revenue beat(2) 1 Avg Revenue beat(2) 1.53%
Min Revenue beat(2) -1.48% Max Revenue beat(2) 4.54%
Revenue beat(4) 2 Avg Revenue beat(4) 0.96%
Min Revenue beat(4) -1.48% Max Revenue beat(4) 4.54%
PT rev (1m) 0% PT rev (3m) 0%
EPS NQ rev (1m) 78.14% EPS NQ rev (3m) 78.14%
EPS NY rev (1m) 0% EPS NY rev (3m) 0%
Revenue NQ rev (1m) 16.83% Revenue NQ rev (3m) 16.83%
Revenue NY rev (1m) 0% Revenue NY rev (3m) 0%

Valuation
Industry RankSector Rank
PE 5.74
Fwd PE 16.72
P/S 1.08
P/FCF 7.11
P/OCF 5.6
P/B 2.06
P/tB 2.16
EV/EBITDA 3.27
EPS(TTM) 9.7 EY 17.43%
EPS(NY) 3.33 Fwd EY 5.98%
FCF(TTM) 7.83 FCFY 14.07%
OCF(TTM) 9.94 OCFY 17.87%
SpS 51.72 BVpS 27
TBVpS 25.75 PEG (NY) 0.03
PEG (5Y) N/A

Profitability
Industry RankSector Rank
ROA 26.84%
ROE 35.84%
ROIC 33.31%
ROICexc 45.03%
ROICexgc 47.74%
OM 24.04%
PM 18.71%
GM 32.57%
ROICexgc(3y) N/A ROICexcg growth 3Y 27.58%
ROICexcg growth 5Y N/A ROICexc(3y) N/A
ROICexc growth 3Y 28.48% ROICexc growth 5Y N/A
OM growth 3Y 31.57% OM growth 5Y N/A
PM growth 3Y 23.3% PM growth 5Y N/A
GM growth 3Y 5.49% GM growth 5Y 35.28%
F-Score 8 Asset Turnover 1.43

Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 149.61%
Profit Quality 80.91%
Current Ratio 3.18
Quick Ratio 2.26
Altman-Z 7.84
F-Score 8 WACC 8.2%
ROIC/WACC 5.82 Cap/Depr(3y) 159.82%
Cap/Depr(5y) 128.05% Profit Quality(3y) N/A
Profit Quality(5y) N/A

Growth
EPS 1Y 6162.5% EPS 3Y 32.69%
EPS 5Y N/A EPS growth Q2Q 20250%
EPS Next Y 193.11% EPS Next 2Y 10.83%
EPS Next 3Y -4.97% EPS Next 5Y N/A
Revenue growth 1Y 78.76% Revenue growth 3Y 9.3%
Revenue growth 5Y 10.59% Revenue growth Q2Q 110.02%
Revenue Next Year 35.95% Revenue Next 2Y 5.96%
Revenue Next 3Y 3.56% Revenue Next 5Y N/A
EBIT growth 1Y 1251.24% EBIT growth 3Y 43.8%
EBIT growth 5Y N/A EBIT Next Year 354.18%
EBIT Next 3Y 11.32% EBIT Next 5Y N/A
FCF growth 1Y 1234.59% FCF growth 3Y 4.54%
FCF growth 5Y N/A OCF growth 1Y 254.58%
OCF growth 3Y 3.12% OCF growth 5Y N/A

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA